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Introduction
Mycobacteria display complex cell walls consisting of gly-
colipids and proteins linked to the mycolyl-arabinogalac-
tan-peptidoglycan backbone (Brennan & Nikaido, 1995; Mc-
Neil & Brennan, 1991). This structure is a major determinant 
of mycobacterial drug resistance and pathogenesis (Daffé 
& Draper, 1998; Trias & Benz, 1994), and its biosynthesis is 
highly conserved among different mycobacterial species 
(Belanger & Inamine, 2000). Intracellular survival is an es-
sential determinant of mycobacterial pathogenesis. To sur-
vive within phagocytic cells, mycobacteria must overcome 
the bactericidal mechanisms of macrophages, including re-
active oxygen intermediates (ROI) and reactive nitrogen in-
termediates (RNI) and lysosomal enzymes (Armstrong & 
Hart, 1975; Lowrie & Andrew, 1988; Sturgill-Koszycki et al., 
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Abstract
d-alanine is a structural component of mycobacterial peptidoglycan. The primary route of d-alanine biosynthesis in eu-
bacteria is the enantiomeric conversion from l-alanine, a reaction catalyzed by d-alanine racemase (Alr). Mycobacte-
rium smegmatis alr insertion mutants are not dependent on d-alanine for growth and display a metabolic pattern con-
sistent with an alternative pathway for d-alanine biosynthesis. In this study, we demonstrate that the M. smegmatis 
alr insertion mutant TAM23 can synthesize d-alanine at lower levels than the parental strain. The insertional inactiva-
tion of the alr gene also decreases the intracellular survival of mutant strains within primary human monocyte-derived 
macrophages. By complementation studies, we confirmed that the impairment of alr gene function is responsible for 
this reduced survival. Inhibition of superoxide anion and nitric oxide formation in macrophages suppresses the differ-
ential survival. In contrast, for bacteria grown in broth, both strains had approximately the same susceptibility to hydro-
gen peroxide, acidified sodium nitrite, low pH and polymyxin B. In contrast, TAM23 exhibited increased resistance to 
lysozyme. d-alanine supplementation considerably increased TAM23 viability in nutritionally deficient media and within 
macrophages. These results suggest that nutrient deprivation in phagocytic cells combined with killing mediated by re-
active intermediates underlies the decreased survival of alr mutants. This knowledge may be valuable in the construc-
tion of mycobacterial auxotrophic vaccine candidates. 
Abbreviations: DCS, d-cycloserine; GPL, glycopeptidolipid; NM-l-Arg, N-methyl-l-arginine; OPA, o-phthaldialde-
hyde; RNI, reactive nitrogen intermediates; ROI, reactive oxygen intermediates; SOD, superoxide dismutase
Three supplementary figures follow the References for this paper; they show growth curves for M. smegmatis paren-
tal, alr mutant, and complemented strains grown in MADC-TW and minimal medium, with or without d-alanine supple-
mentation, and the susceptibility of M. smegmatis to hydrogen peroxide and sodium nitrite.
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1994). Studies on auxotrophic mutants have demonstrated 
that nutritional status also plays a role in the intracellular 
survival of mycobacteria within macrophages (De Voss et al., 
2000; Hondalus et al., 2000; Jackson et al., 1999). 
Mycobacterium smegmatis, a fast-growing species of low 
pathogenicity, displays a basal but measurable level of re-
sistance to macrophage killing. Studies with this micro-or-
ganism have been conducted using a diverse array of mac-
rophages (Jordao et al., 2008), including murine (Anes et 
al., 2006; Kuehnel et al., 2001) and human (McGarvey et al., 
2004; Miller & Shinnick, 2000) cell lines, and tissue-derived 
macrophages of murine (Kocincova et al., 2009; Singh et al., 
2008; Wagner et al., 2005) or human origin (Garg et al., 2006; 
Lagier et al., 1998). M. smegmatis interaction with mouse 
phagocytic cells results in generation of ROI and RNI, in-
cluding nitric oxide (Anes et al., 2006). In vitro susceptibil-
ity of M. smegmatis to RNI is well documented (Yu et al., 
1999). In addition, expression of Mycobacterium tuberculosis 
genes in M. smegmatis alters its resistance to macrophage 
killing, and this effect has been widely used in the identifi-
cation of mycobacterial genes involved in intracellular sur-
vival of pathogenic mycobacteria (Miller & Shinnick, 2000; 
Singh et al., 2008). Since M. smegmatis has a high-efficiency 
genetic transfer system and fast growth, it has been used 
as an affordable model to study mycobacterial physiology, 
including the effects of metabolic changes on intracellular 
survival, gene expression and regulation, and this is espe-
cially meaningful for the study of highly conserved path-
ways (Caceres et al., 1997; Danilchanka et al., 2008; Garg et 
al., 2006; Glover et al., 2007; Lagier et al., 1998; Posey et al., 
2006; Provvedi et al., 2008). 
d-alanine is a structural component of mycobacterial 
peptidoglycan (Strominger, 1962). d-alanine racemase ca-
talyses the primary route of d-alanine biosynthesis in my-
cobacteria (Chacon et al., 2002). d-alanine is also present 
in the core head group of glycopeptidolipids (GPLs) of 
many mycobacterial species, with Mycobacterium xenopi 
illustrating the only exception among those species an-
alyzed (Brennan & Nikaido, 1995; Eckstein et al., 2003; 
Etienne et al., 2005; Riviere & Puzo, 1991). Genetic anal-
ysis of the d-alanine branch of peptidoglycan biosynthe-
sis in mycobacteria was first carried out in M. smegma-
tis, which possesses, as does M. tuberculosis, only one alr 
gene (Caceres et al., 1997; Cole et al., 1998). We have dem-
onstrated that d-alanine racemase insertion mutants (alr) 
are not dependent on d-alanine for growth (Chacon et al., 
2002). These mutants also exhibit increased susceptibility 
to the bactericidal agent d-cycloserine (DCS), a d-alanine 
analogue used as a second-line drug in tuberculosis treat-
ment. We hypothesized that disrupting d-alanine biosyn-
thesis would also impair survival in macrophages, as a re-
sult of modifications in the cell envelope and/or nutrient 
deprivation in phagocytic cells. In this study we deter-
mine the levels of d-alanine biosynthesis and the survival 
of M. smegmatis parental and alr mutant strains under var-
ious extracellular conditions and in human monocyte-de-
rived macrophages. 
Methods
Bacterial strains, plasmid vectors and growth conditions. Bacte-
rial strains and vectors used in this study have been previously de-
scribed (Chacon et al., 2002). Escherichia coli DH5α was grown as de-
scribed elsewhere (Sambrook et al., 1989). M. smegmatis parental strain 
mc2155 (Snapper et al., 1990), its derived alr mutant TAM23 (Chacon 
et al., 2002), and their transformants with the integrating vectors 
pYUB178 (Pascopella et al., 1994), pYUB412 (Pavelka & Jacobs, 1999) 
and pTAMU3 (Chacon et al., 2002), were grown at 37 °C with shak-
ing (200 r.p.m. with an Innova 4300, New Brunswick Scientific) to 
OD600 ~1.0. Supplements for complete Middlebrook 7H9 (BBL Micro-
biology Systems) medium were 0.2% (v/v) glycerol (Sigma-Aldrich), 
0.05% Tween 80 (Sigma-Aldrich) to prevent clumping, 0.01% cyclo-
heximide (A.G. Scientific) to prevent fungal contamination, and ADC 
[0.5% bovine fraction V albumin (Amresco), 0.01 M glucose (Acros), 
and 0.015 M NaCl (MADC-TW)]. Broth minimal medium was pre-
pared as previously described (Chacon et al., 2002). Generation times 
were determined as described elsewhere (Miller, 1972). c.f.u. were es-
timated from optical density measurements using appropriate cali-
bration curves. In addition, M. smegmatis c.f.u. were determined after 
incubation at 37 °C on MADC agar (Tween 80 was omitted from all 
solid media) or appropriately supplemented 7H9 basal medium pre-
pared with 15 g Bacto agar l−1 (Difco Laboratories). d-alanine (Sigma-
Aldrich) was added at 50 mM as necessary to broth cultures and agar 
plates. 
Analysis of amino acid intracellular pools. Steady-state levels of 
intracellular amino acid pools were determined as previously de-
scribed (Feng & Barletta, 2003). M. smegmatis strains mc2155 and 
TAM23 were grown in 250 ml minimal medium with 21 mM glyc-
erol (carbon source) and 5 mM NH4Cl (nitrogen source) to expo-
nential phase (OD600 0.5–0.9), treated for 2 h with or without DCS 
at 75 μg ml−1, harvested, washed and sonicated to prepare cell-
free protein-free extracts as previously described (Chacon et al., 
2002). Protein was removed from the supernatant by serial pas-
sages through YM-10 and YM-3 Centricon concentrators (Millipore 
Corporation). Determination of amino acids was performed at the 
Amino Acid Geochronology Laboratory of Northern Arizona Uni-
versity (Flagstaff, AZ) by a reverse-phase HPLC procedure as de-
scribed elsewhere (Kaufman & Manley, 1998). This procedure was 
able to detect nine pairs of l- and d-amino acids in the subpicomo-
lar range based on the derivatization reaction of amino acids with 
o-phthaldialdehyde (OPA) and the chiral compound N-isobutyryl-
l-cysteine. The synthetic amino acid l-homo-arginine (l-hArg) was 
spiked in the samples at 10 μM as an internal standard. The to-
tal amount of amino acids in the recovered pools was averaged for 
each strain/treatment combination and expressed as micromoles to-
tal OPA-derivatized product per 1 × 109 cells. Relative abundance 
percentiles of individual amino acids were calculated as a molar 
percentage of the total pool for each sample. 
Intracellular killing assays. Intracellular killing assays were carried 
out as described previously, with some modifications (Bermudez & 
Young, 1988). Prior to infection, M. smegmatis cells were grown in 
MADC-TW with and without d-alanine to OD ~1.0, harvested, and 
resuspended in Hanks’ Balanced Salts Solution (HBSS; Sigma-Al-
drich). Cells were passed through a membrane filter (1.2 μm pore-
size, Millipore) to obtain a single-cell suspension, and sedimented 
for 5 min at room temperature. Macrophages were infected with 
1.0 ml supernatant appropriately diluted in HBSS. Monocytes (1.0–
5.0×105 per well) derived from blood of healthy human donors were 
seeded in tissue-culture plates (Sigma-Aldrich) and incubated for 
2 h at 37 °C in 5% CO2. Procedures for blood collections were per-
formed in compliance with all federal and local regulations. Super-
natant fluids with non-adherent cells were removed and the wells 
were washed twice with 1.0 ml prewarmed HBSS. The adherent 
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monocytes were maintained in culture for 7 days with 1.5 ml com-
plete RPMI 1640 (Invitrogen) medium supplemented with 2 mM l-
glutamine (Sigma-Aldrich) and 10% heat-inactivated fetal bovine se-
rum (Sigma-Aldrich), and d-alanine where indicated; the medium 
was replaced every 48 h. 
Macrophage monolayers were infected at an m.o.i. of 1 or 10 bacilli 
per cell, as indicated. Monolayers were incubated for 1–2 h at 37 °C in 
5% CO2 followed by three washes with HBSS to remove extracellular 
micro-organisms. Similar washes were performed at each time point. 
An m.o.i. of 1 bacillus per cell was used as necessary to maximize the 
effects of host cell restriction on bacterial growth. For inhibitor treat-
ment assays, cells were split 30 min post-infection and supplemented 
as indicated with bovine superoxide dismutase (SOD; Sigma-Al-
drich), human catalase (Sigma-Aldrich), or the nitric oxide (NO) syn-
thase inhibitor N-methyl-l-arginine (NM-l-Arg; Sigma-Aldrich) fol-
lowing previously described procedures (Bermudez & Young, 1989; 
Bermudez, 1993). Cells were lysed at 1 or 2, 24, 48 (except inhibitor 
assays) and 72 h with 0.5 ml sterile double-distilled H2O (ddH2O) for 
10 min and 0.025% SDS (Sigma-Aldrich) in HBSS for another 10 min. 
SDS was subsequently removed with 0.1% bovine albumin and the 
lysate was plated on MADC. Three replicate wells were used per ex-
perimental group, in at least two independent experiments. 
Cell viability was determined by trypan blue exclusion as pre-
viously described (Bermudez & Young, 1988). The viability of the 
cell monolayer post-infection decreased slightly from 98–99% (1 h) 
to 90–92% (24 h), 84–86% (48 h) and 73–77% (72 h). No significant 
differences were observed at each time point in the viability of mac-
rophage monolayers subjected to different treatments or infected 
with various strains. To verify that the addition of SDS did not det-
rimentally affect the viability of the M. smegmatis parental and alr 
mutant strains, ~5.0×106 c.f.u. were treated with ddH2O for 10 min 
and 0.025% SDS for 10 min, and 0.1% albumin was added. Bacteria 
were plated to determine c.f.u. There were no significant differences 
for the titer of either mc2155 (P = 0.7662) or TAM23 (P = 0.6901) 
strains before and after treatment, or between mc2155 and TAM23 
(P = 0.9422) in their susceptibility to SDS. Another experiment using 
20 μg amikacin ml−1 (Sigma-Aldrich) during invasion yielded sim-
ilar results, demonstrating the effectiveness of the washing proce-
dure for removing extracellular bacteria (data not shown). 
Susceptibility assays. Susceptibility assays with M. smegmatis cells 
grown in MADC-TW were carried out at different treatment agent 
levels (hydrogen peroxide, lysozyme and polymyxin B sulfate) or the 
kinetics of killing was followed at a standardized level of the agent 
(sodium nitrite, hydrochloric acid and lysozyme). The effect of hydro-
gen peroxide (H2O2) on the viability of M. smegmatis was determined 
as described elsewhere (Yu et al., 1998). Cell cultures were grown with 
or without d-alanine, harvested, washed with PBS-Tween 80 (PBS-
TW), resuspended in the same volume of PBS-TW, and treated with 
0–30 mM H2O2 (Sigma-Aldrich) in 5 mM increments. Cells were in-
cubated for 30 min at 37 °C, washed with MADC-TW, and plated on 
MADC supplemented with d-alanine. To determine the effects of ly-
sozyme, cells were plated on MADC with 0, 500, 750 and 1000 μg ml−1 
of hen egg-white lysozyme (Sigma-Aldrich). To determine the sus-
ceptibility to the model antimicrobial cationic peptide polymyxin B 
(sulfate salt, Invitrogen), bacteria were plated on MADC with 0, 16, 
32, 64 and 96 μg ml−1 of this antimicrobial peptide. 
Sodium nitrite (NaNO2) susceptibility was determined as previ-
ously described (Firmani & Riley, 2002), with modifications. Cell al-
iquots (0.5 ml) were adjusted to ~1.0×106 c.f.u. ml−1 and added to 
MADC-TW at pH 4.0 or 6.5 adjusted with HCl and 0, 2, 4 or 6 mM 
NaNO2 (Sigma-Aldrich). Samples were collected at 0, 2, 5 and 24 h 
post-treatment. For susceptibility to HCl alone, 0.5 ml cell aliquots 
(adjusted to ~1.0×108 c.f.u. ml−1) were combined with MADC-TW at 
pH 4.0 adjusted with HCl. Samples were taken at 0, 7, 12, 24, 48, 72 
and 96 h after treatment. To follow the kinetics of lysozyme, cells were 
grown in MADC-TW with or without 500 μg lysozyme ml−1. Samples 
were collected at 0, 3, 6, 12 and 24 h post-treatment and washed with 
MADC-TW. In all cases, c.f.u. were determined on MADC agar. 
MICs were determined by a previously described microdilution 
method (Chacon et al., 2002). Two compounds were tested: imipe-
nem (compound MK0787, US Pharmacopeia), a β-lactam transpepti-
dase inhibitor with broad-spectrum anti-microbial activity (Kesado et 
al., 1980); and vancomycin (Sigma-Aldrich), a glycopeptide that binds 
to d-alanyl-d-alanine moieties (Perkins & Nieto, 1974). Briefly, cells 
were grown in MADC-TW to mid-exponential phase (OD600 0.6–1.0), 
adjusted to ~1.0×105  c.f.u. in 0.1 ml, and inoculated into 96-well mi-
croplates containing serial twofold dilutions of the corresponding an-
timicrobial agent. The MIC was defined as the minimal drug concen-
tration that prevented visible bacterial growth at 37 °C after 48 h. 
Effects of nutritional supplements on M. smegmatis growth. 
Strains mc2155 and TAM23 were grown in MADC-TW without and 
with d-alanine, respectively. Bacteria were washed twice with PBS-
TW, resuspended in the original volume of PBS-TW, and plated 
on 7H9 basal agar without and with supplementation with 0.15% 
(v/v) glycerol; 50 mM d-alanine; 0.5% (w/v) albumin; 10 mM glu-
cose; albumin, glucose and d-alanine; or glycerol, ADC and d-ala-
nine (MADC+d-alanine). 
Statistical and graphical analysis. Statistical analyses were per-
formed using SAS version 9.1.3, 2004 (SAS Institute). Log-trans-
formed c.f.u. were analyzed as a repeated measure design and in-
cluded the effects for strain and treatment, and their interaction. 
The repeated measures analyses were carried out using the Mixed 
procedure. The covariance structure for each analysis was selected 
based on the Schwarz’s Bayesian Criterion. Post-hoc comparisons 
for the amino acid analysis were carried out using Tukey adjusted P 
values; for the nutritional supplement analysis, Bonferroni adjusted 
P values were used. The Cluster procedure was used to determine 
the average linkage distance (joins clusters with small variances) be-
tween strains grouped together. For the H2O2, lysozyme and poly-
myxin B analyses, LD50 values were estimated for each strain rep-
licate combination using the Probit procedure. These LD50 values 
were then analyzed as a one-way ANOVA. Contrast and estimate 
statements were used to determine the statistical significance for 
line graphs. Bar and line graphs were constructed using DeltaGraph 
version 5.6.2 (Red Rock Software). 
Results
Extracellular growth of M. smegmatis strains in broth 
with and without d-alanine 
Extracellular growth of M. smegmatis strains was evalu-
ated in broth media. In MADC-TW (with glycerol, l-glu-
tamate and ammonium chloride as carbon and nitrogen 
sources), mc2155 started growing immediately with a 
generation time of 165 ±23 min, reaching a maximum at 
OD600 3.2 (Supplementary Figure S1a). When d-alanine 
was added, the mc2155 generation time was longer (195 
±27 min), reaching an upper limit at OD600 1.7. TAM23 
grew with about the same generation time in MADC-TW 
with (225 ±32 min) and without (210 ±30 min) d-alanine. 
Both values were greater than those for mc2155 (Supple-
mentary Figure S1b). However, the yield was higher with 
d-alanine than in its absence, as OD600 values were 2.6 and 
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1.4, respectively. In addition, growth in the absence of d-
alanine was characterized by a lag time of 30 ±4 h that did 
not occur with d-alanine. Complementation of TAM23 
with the integrating vector pTAMU3, which carries the 
wild-type alr gene, restored parental properties. The gen-
eration times of TAM23 (pTAMU3) in the presence and 
absence, of d-alanine were 210 ±30 and 180 ±25 min, re-
spectively. More importantly, this recombinant strain 
grew in the absence of d-alanine without a lag time (Sup-
plementary Figure S1c), reaching OD600 3.0, similar to 
the wild-type strain. As expected in the presence of d-al-
anine, TAM23(pTAMU3) reached a lower OD600 value of 
2.1. Growth patterns were also determined in nutrient-
restricted minimal medium with glycerol (sole carbon 
source) and ammonium chloride (sole nitrogen source). 
Similar results were obtained for the parental and com-
plemented strains, but TAM23 grew with longer gener-
ation and lag times in the absence of d-alanine (Supple-
mentary Figure S2). A second passage of TAM23 without 
d-alanine resulted in a growth pattern similar to that of 
mc2155, displaying no lag time (Chacon et al., 2002). 
Biosynthesis of d-alanine in an M. smegmatis alr inser-
tion mutant 
The d-alanine-independent phenotype of M. smegmatis alr 
insertion mutants suggests that M. smegmatis possesses an 
alternative pathway of d-alanine biosynthesis (Chacon et 
al., 2002; Halouska et al., 2007). Alternatively, this micro-or-
ganism may be able to synthesize peptidoglycan and other 
essential components without d-alanine. To distinguish be-
tween these two alternative hypotheses, we determined 
whether the mutant strain could synthesize d-alanine. 
Strains mc2155, mc2155 treated with the Alr inhibitor 
DCS, and TAM23 synthesized approximately the same 
level of total amino acids, as quantified by OPA (Figure 1, 
inset). This result demonstrates that bacteria do not com-
pensate for the alr mutation by making more of all amino 
acids. However, significant changes in their relative abun-
dance were observed (Figure 1). When compared with 
untreated mc2155, mc2155 with DCS (P = 0.0061) and 
TAM23 (P = 0.0005) yielded a 14 and 25% decrease in the 
highly abundant l-glutamate-l-glutamine (l-Glx) pool, re-
spectively. This result is consistent with the decrease in 
the overall glutamate pool observed in our TAM23 me-
tabolomic analysis (Halouska et al., 2007). Significant in-
creases were observed in the l-alanine (l-Ala) pools for 
TAM23 (about 4.5-fold, P < 0.0001) and mc2155 with DCS 
(about 1.7-fold, P = 0.0003) compared to mc2155. A de-
creasing trend was detected in the d-alanine (d-Ala) pools 
upon treatment with DCS or in TAM23. These results 
further confirm our metabolomic studies, but the cur-
rent analysis shows that the total increase in the alanine 
pools is determined by higher levels of the l-enantiomer. 
Though not significant at the P < 0.05 level, similar trends 
were seen for the total l(d)-aspartate-l(d)-asparagine 
(l-Aspx/d-Aspx) pools. 
In all cases, mc2155 with DCS followed the same trend 
as TAM23, but TAM23 displayed the most extreme val-
ues, as expected from the complete inactivation of the alr 
gene, in contrast to the DCS inhibition of Alr enzyme ac-
tivity. Importantly, the internal d-Ala pools, although ap-
proximately 3.5-fold less than those of mc2155, were above 
background levels. Thus, inhibition of the Alr enzyme by 
DCS or impairment of alr gene function has a significant in-
fluence on alanine metabolism, leading to a decrease in the 
d-Ala pool and an accumulation of l-Ala. The l-Ala:d-Ala 
ratio was 1.7:1 for mc2155, 10:1 for mc2155 with DCS, and 
28:1 for TAM23. 
M. smegmatis alr mutants display impaired survival in 
human macrophages 
Since alr insertion mutants displayed poor growth in me-
dia without d-alanine, we hypothesized that d-alanine lim-
itation would also lead to decreased intracellular survival 
in the nutrient-limiting macrophage environment. To max-
Figure 1. Intracellular M. smegmatis steady-state amino acid pools. 
Standard amino acid nomenclature is used and results are reported 
as mean ±sem, n = 2–4. Symbols: striped bars, mc2155 without DCS; 
white bars, mc2155 with DCS; black bars, TAM23 without DCS. In-
set: the total amino acid pool (total OPA-derivatized product) recov-
ered from 1×109 cells. Statistical significance is indicated as follows: 
*P = 0.01–0.05; **P = 0.001–0.01; ***P < 0.001. Pairwise determina-
tions are displayed as follows: the upper left compares mc2155 without 
DCS to mc2155 with DCS, the upper right compares mc2155 with DCS 
to TAM23, and the lower middle compares mc2155 to TAM23. All other 
comparisons were not significant (P > 0.05). 
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imize potential differences, macrophage monolayers were 
infected with bacilli grown in medium without d-alanine. 
The uptake levels at 2 h post-infection for both parental 
and mutant strains were similar (Figure 2). As expected, 
mc2155 displayed moderate survival in macrophages, 
while TAM23 survived very poorly (P < 0.0001). The com-
plemented strain TAM23 (pTAMU3) displayed similar 
survival levels at 48 h (P = 0.3867) and 72 h (P = 0.2473) 
compared with mc2155. This result confirmed that the inac-
tivation of the alr gene is responsible for the reduced intra-
cellular survival of TAM23. 
In addition, we tested the effects of selection markers on 
the survival of M. smegmatis in phagocytic cells (Figure 2). 
Strain mc2155 (pYUB178), which carries the kanamycin-re-
sistance marker used to inactivate the alr gene, displayed a 
survival trend similar to that of the parental strain at 48 h 
(P = 0.3475), indicating that this marker does not affect 
the intracellular survival of M. smegmatis. Strain mc2155 
(pYUB412), which carries the hygromycin-resistance com-
plementing vector, displayed an increase in intracellu-
lar survival at all time points as compared with TAM23 (P 
< 0.0001). At 24 h post-infection, TAM23 (pYUB412) dis-
played a similar fivefold reduction in intracellular sur-
vival as seen for TAM23; however, at 48 and 72 h, TAM23 
(pYUB412) displayed an intermediate level of survival 
when compared with mc2155 and TAM23. Thus, the hy-
gromycin-resistance marker influences intracellular sur-
vival at longer times post-infection. Nonetheless, the effect 
is different from the complete recovery of TAM23 survival 
conferred, at every time point post-infection, by the hygro-
mycin-resistance integrating vector pTAMU3 carrying the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
wild-type alr gene. In summary, global analysis of survival 
data indicated that each strain displayed a unique sur-
vival curve (P < 0.0001). However, cluster analysis grouped 
mc2155, TAM23 (pTAMU3) and mc2155 (pYUB178) to-
gether with a normalized root mean square distance 
(NRMSD) of 0.27. This cluster was separated from the 
TAM23 (pYUB412) (NRMSD = 0.73) and TAM23 (NRMSD 
= 1.43) clusters. Thus, the inactivation of the alr gene has a 
significant effect on the ability of M. smegmatis to survive 
within phagocytic cells (P < 0.0001). 
Susceptibility of M. smegmatis to bactericidal agents 
Experiments were performed to further define the sus-
ceptibilities of wild-type and alr mutant strains to agents 
that mediate or enhance intracellular bactericidal ac-
tion in macrophages. Susceptibilities to reactive interme-
diates were first assessed on bacteria grown in broth by 
determining the effects of H2O2 and acidified NaNO2. As 
shown in Supplementary Figure S3(a), no significant dif-
ferences were observed in the susceptibilities to H2O2 (P 
= 0.0544) of mc2155 without d-alanine (LD50 9.73%, v/v), 
mc2155 with d-alanine (LD50 9.57%, v/v), TAM23 with-
out d-alanine (LD50 13.34%, v/v) and TAM23 with d-al-
anine (LD50 9.10%, v/v). Likewise, no significant differ-
ences were observed between mc2155 and TAM23 treated 
and not treated with NaNO2 (P = 0.1198) over a 24 h pe-
riod (Supplementary Figure S3b). 
Susceptibilities to ROI and RNI within macrophages 
were also tested using inhibitors (Figure 3). Treatment of 
monolayers with the H2O2-detoxifying enzyme catalase did 
not result in significant differences for mc2155 (P = 0.1544) 
or TAM23 (P = 0.6225) as compared with the corresponding 
untreated controls, while major differences were observed 
between strains (P = 0.0002). Scavenging of superoxide an-
ion with SOD led to significant differences for TAM23 (P 
< 0.0001) as compared with the untreated control, while a 
minor effect was observed for mc2155 (P = 0.1316 compar-
ing all time points, P = 0.0158 at 72 h). However, no signifi-
cant differences were observed between strains upon SOD 
treatment (P = 0.6116). Inhibition of NO synthase with NM-
l-Arg resulted in a significant increase in the survival of 
mc2155 (P = 0.0238) and TAM23 (P < 0.0001) as compared 
with the corresponding untreated controls, with no differ-
ence between the strains (P = 0.9171), indicating that pro-
duction of reactive intermediates plays an important role 
in differential killing. 
Upon phagolysosomal fusion, mycobacteria may be ex-
posed to acid pH, lysosomal enzymes and cationic pep-
tides. Exposure of mc2155 and TAM23 to pH 4.0 (without 
NaNO2) for 24 h did not result in significant differences 
(Supplementary Figure S3b). Furthermore, extending the 
pH treatment to 96 h yielded the same outcome (data not 
shown). The potential effects of the alr mutation on the 
peptidoglycan structure may result in altered susceptibil-
Figure 2. Intracellular survival of M. smegmatis in human macro-
phages. Monolayers were infected at an m.o.i. of 10 bacilli per cell with 
mc2155 (●), TAM23 (■), TAM23 (pTAMU3) (▲), TAM23 (pYUB412) 
(▼) or mc2155 (pYUB178) () grown in Middlebrook media without d-
alanine. Results are reported as mean ±sem, n = 3, with statistical sig-
nificance indicated as ***, P < 0.001. 
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ity to lysozyme and polymyxin B. Treatment with 500 or 
750 μg lysozyme ml−1 decreased survival of mc2155 (~95%) 
and TAM23 (~85%) (P = 0.0344), with a more pronounced 
effect (~98% for both strains) at 1000 μg lysozyme ml−1 
(Figure 4a). Significant differences were observed in the 
susceptibilities to lysozyme of mc2155 (LD50 47 μg ml−1) 
and TAM23 (LD50 205 μg ml−1). To confirm these results, 
the bactericidal action of 500 μg lysozyme ml−1 was also 
followed in MADC-TW 24 h post-treatment (Figure 4b). 
The survival dropped 500- (TAM23) to 4500-fold (mc2155), 
indicating that lysozyme has a greater bactericidal action 
on the parental strain (P < 0.0001), although the survival 
curves follow similar trends. Thus, the changes in TAM23 
appear to make its peptidoglycan less susceptible to lyso-
zyme. In contrast, TAM23 was slightly more susceptible to 
polymyxin B than mc2155 (Figure 4c), although this trend 
did not reach statistical significance (P = 0.0660). 
We have reported the hypersusceptibility of TAM23 
to DCS with an MIC of 2.56 μg ml−1, as compared with 
75 μg ml−1 for mc2155, while the susceptibilities to ami-
kacin, ethambutol and ribafutin remain at parental levels 
(Chacon et al., 2002). In this study, the MICs against two 
additional drugs related to peptidoglycan structure were 
determined. Mutant TAM23 was significantly more sus-
ceptible to imipenem (MIC 0.625 versus 20 μg ml−1) and 
vancomycin (MIC 1.56 versus 12.5 μg ml−1). These results 
are consistent with peptidoglycan alterations as a result of 
the downshift in the d-alanine pool. 
Figure 3. Effect of reactive intermediate inhibitors on the intracel-
lular survival of M. smegmatis in human macrophages. Monolay-
ers were infected at an m.o.i. of 1 bacillus per cell with either mc2155 
(●) or TAM23 (■) grown in Middlebrook medium without d-alanine. Af-
ter 30 min, cells were split and either not treated (unbroken lines) or 
treated with SOD (dashed–dotted lines), catalase (dashed lines) or 
NM-l-Arg (nearly overlapping; dotted lines). Results are reported as 
mean ±sem, n = 2. 
Figure 4. Susceptibility of M. smegmatis to lysozyme and polymyxin 
B. For lysozyme assays, cells were plated at various concentrations 
(a) or treated with 500 μg ml−1 for different time periods (b). For poly-
myxin B assays (c), cells were plated at various concentrations. Sym-
bols and line patterns are: ●, mc2155; ■, TAM23; ——, mc2155 and 
TAM23 with lysozyme; ∙∙∙∙∙∙∙∙, mc2155 and TAM23 without lysozyme. 
Results are reported as mean ±sem, n = 3, with statistical significance 
displayed as NS, not significant (P > 0.05); *, P = 0.01–0.05; **, P = 
0.001–0.01; ***, P < 0.001. 
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Effect of nutritional supplements on M. smegmatis 
growth 
Macrophages restrict nutrients to phagocytosed bacte-
ria, an effect that has been termed a nutriprive mecha-
nism (Appelberg, 2006). This restriction may include essen-
tial ions (Wagner et al., 2005), purines, pyrimidines, amino 
acids and vitamins. To test the effects of nutritional sup-
plementation, parental and mutant cells were plated on 
various solid media. As shown in Table 1, significant dif-
ferences were found between mc2155 and TAM23 on 7H9 
basal medium and 7H9 supplemented with glycerol or d-
alanine. No significant differences were observed for the 
remaining supplementations. Comparing the growth per-
formance of each strain individually in the various media, 
both strains performed best and equally well on basal agar 
with albumin, glucose and d-alanine; and MADC plus d-
alanine (P = 1.00). Intermediate growth was observed for 
both strains with the addition of glycerol, d-alanine, albu-
min or glucose to the basal medium. Basal agar yielded the 
poorest growth for both strains with a more prominent ef-
fect on TAM23. These observations confirmed that alr in-
sertional mutants grow better with d-alanine, but are not 
dependent on this nutrient. 
To test for the effect of d-alanine in macrophages, pa-
rental and mutant strains were grown in MADC with 
or without d-alanine prior to the infection of monolay-
ers cultured without d-alanine. The uptake of mc2155 
and TAM23 by monolayers of adherent human macro-
phages 1 h post-infection was similar, regardless of d-al-
anine supplementation (Figure 5a). As expected, mc2155 
grown in broth with or without d-alanine displayed sim-
ilar survival in macrophages (P = 0.309), but TAM23 sur-
vived better when grown in broth with d-alanine (P < 
0.0001). As described above (Figure 2), mc2155 survived 
better than TAM23 (P < 0.0001, for all pairwise compar-
isons). A similar effect was obtained when TAM23 was 
grown without d-alanine and macrophage monolay-
ers were incubated with or without d-alanine during the 
course of the infection (Figure 5b). In the absence of d-al-
anine, TAM23 was less able to survive as compared with 
conditions in which monolayers were supplemented with 
d-alanine (P = 0.0166). In summary, the difference in the 
viability of both strains in basal media reflected the intra-
cellular survival data well. 
Discussion
The goal of this study was to analyze the physiological con-
sequences of the insertional inactivation of the alr gene in 
M. smegmatis in the context of both extracellular and intra-
cellular survival. We have shown that alr insertion mutants 
are not dependent on d-alanine for growth, and display 
changes in colony morphology, metabolomic profiling and 
hypersusceptibility to DCS (Chacon et al., 2002; Halouska 
et al., 2007). We hypothesized that alr mutants synthesize 
d-alanine by an alternative pathway. In contrast, another 
study indicates that M. smegmatis alr deletion mutants are 
auxotrophic for d-alanine (Milligan et al., 2007). However, 
there are significant differences in the experimental design 
that led to mutant isolation and characterization in the two 
studies, including a two-step procedure and shorter fol-
low-up incubation in the study of the alr deletion mutants. 
Furthermore, metabolomic analysis of the TAM23 alr in-
sertion mutant indicates metabolic changes more readily 
compatible with the activation of an alternative pathway of 
d-alanine biosynthesis (Halouska et al., 2007). Thus, the dif-
ferences between these two studies may reflect changes in 
the experimental conditions. 
In this study, the analysis of the amino acid pools indi-
cates that the TAM23 alr mutant exhibits lower, but above 
background, levels of d-alanine and l-glutamate and ac-
cumulation of l-alanine, as compared with the parental 
strain. These results are consistent with our hypothesis 
and previous studies (Chacon et al., 2002; Halouska et al., 
2007). As expected, the effect of alr insertional inactiva-
tion on these amino acid pools is more pronounced than 
the effect of DCS, an Alr inhibitor. Thus, insertional inac-
tivation of the alr gene in TAM23 results in markedly re-
duced availability of d-alanine (indicated by a low d-al-
anine pool in the mutant), possibly leading to decreased 
incorporation of this amino acid into peptidoglycan and 
glycolipids. Structural analyses will be conducted to test 
this hypothesis. 
The insertional inactivation of the M. smegmatis alr gene 
resulted in 80% reduction in the intracellular survival of 
the mutant strain in monocyte-derived human macro-
phages at 24 h post-infection (Figure 2). This effect is con-
siderably more pronounced than the 20–50% reduction 
observed for other M. smegmatis mutants under similar 
conditions (Lagier et al., 1998). The conservation of basic 
Table 1. M. smegmatis cell viability on Middlebrook 7H9 basal agar 
with and without supplementation 
Supplementation                              Mean log(c.f.u.)*  P value†
 mc2155  TAM23
None  3.67  0.60  <0.0001
Glycerol (0.15 %, v/v)  4.91  4.29  <0.0001
d-Alanine (50 mM)  4.92  3.74  <0.0001
Albumin (0.5 %, w/v)  4.80  4.57  0.2435
Glucose (10 mM)  4.96  4.79  0.6492
Albumin + glucose + d-alanine  5.77  5.71  0.9999
Glycerol + ADC + d-alanine 5.78  5.76  1.0000
    (MADC + d-alanine) 
*Strains mc2155 (without 50 mM d-alanine) and TAM23 (with 50 mM d-
alanine) were grown at 37 °C in MADC-TW to OD600 ~1.0, washed 
twice in PBS-TW, and plated on solid media (SEM = 0.056, n = 3).
† Bonferroni adjustment (significant at P < 0.007).
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metabolic pathways in mycobacteria plus the effect of alr 
mutation on extracellular and intracellular survival of M. 
smegmatis would predict a considerable degree of attenua-
tion for alr mutant strains of pathogenic mycobacterial spe-
cies, provided viable mutants could be obtained. 
Pathogenic mycobacteria have greater ability to evade 
bactericidal mechanisms such as phagosome acidifica-
tion, while M. smegmatis fails to prevent this process (Stur-
gill-Koszycki et al., 1994). However, intracellular bacilli of 
both M. smegmatis and pathogenic mycobacterial species 
are exposed to killing by reactive intermediates (Anes et al., 
2006; Jordao et al., 2008; Nathan & Shiloh, 2000; Shiloh & 
Nathan, 2000), though controversial results have been ob-
tained (Ehrt et al., 1997). In our case, extracellular treatment 
with H2O2, NaNO2 and acidic pH had a bactericidal action 
on M. smegmatis, but did not reveal any major survival dif-
ferences between the strains. H2O2 scavenging by catalase 
treatment of infected monolayers had no effect on the via-
bility of any of the strains as compared with untreated con-
trols. However, scavenging of superoxide anion by SOD or 
inhibition of NO synthase by the specific inhibitor NM-l-
Arg resulted in decreased bactericidal activities in macro-
phage monolayers. This effect was more pronounced in the 
alr mutant. This suggests that in our experimental condi-
tions, reactive intermediates have an important role in M. 
smegmatis killing by human macrophages, as indicated in 
Figure 3. Since RNI inhibition may not affect superoxide 
anion production by the phagocyte oxidase pathway, it is 
possible that SOD scavenging of superoxide only limits its 
conversion to peroxynitrite, a highly bactericidal product 
formed from superoxide and NO. In contrast, other stud-
ies have failed to detect reactive intermediates and con-
clude that these molecules do not have a major role in M. 
smegmatis killing by human monocytes (Jordao et al., 2008). 
However, these molecules are difficult to detect, given their 
short life and low concentrations in the macrophages (For-
man & Torres, 2001; Valko et al., 2007). 
The results presented herein suggest that the use of in-
hibitors is a more reliable indicator of the involvement of 
reactive intermediates than the failure to detect relatively 
low levels of these molecules by the Griess reaction. This 
situation is particularly critical in our study, since the hu-
man monocytes were not activated with γ-interferon. 
Nonetheless, infection with M. smegmatis (Ehrt et al., 1997), 
maturation in culture (Martin & Edwards, 1993), and spe-
cific experimental conditions may sufficiently increase re-
active intermediate levels, especially for RNI, to have bac-
tericidal action on this micro-organism, as suggested by 
our inhibition studies. Activation of the arginase pathway 
reduces arginine availability for the NO synthase reaction 
in murine macrophages (Martin et al., 2006). This leads to 
an increase in intracellular levels of l-glutamate. A similar 
effect might be possible upon NO synthase inhibition by 
NM-l-Arg. Since l-glutamate seems to be involved in the 
alternative pathway of d-alanine biosynthesis in M. smeg-
matis alr mutants, this effect could increase the survival of 
the mutant strain to wild-type levels in the absence of d-
alanine (Figure 5). The differential microbicidal effect on 
TAM23 in untreated macrophages may also reflect the in-
creased permeability of the mutant strain to reactive inter-
mediates. In either case, preloading of TAM23 cells with 
d-alanine or its addition to monolayers had a partially com-
Figure 5. Effect of d-alanine on the intracellular survival of M. smegmatis in human macrophages. Monolayers were infected at an m.o.i. of 1 ba-
cillus per cell with either mc2155 (●) or TAM23 (■) grown in Middlebrook media. (a) Bacilli were grown in broth with (dashed lines) or without (un-
broken lines) d-alanine. (b) Bacilli were grown in broth without d-alanine and macrophage monolayers were incubated with (dashed lines) or with-
out (unbroken lines) d-alanine. Results are reported as mean ±sem, n = 3, with statistical significance displayed as NS, not significant (P > 0.05); 
*, P = 0.01–0.05; ***, P < 0.001. 
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pensatory effect (Figure 5). Thus, the effects of nutrient de-
privation in phagocytic cells combined with killing medi-
ated by reactive intermediates determined the differential 
survival of the strains. The decreased pool of d-alanine 
might also result in a further reduction in the GPL content 
of TAM23, affecting both colony morphology and suscepti-
bility to macrophage killing (Kocincova et al., 2009). 
Additional bactericidal mechanisms operate in lyso-
somal compartments. In this context, we observed a slight 
decrease rather than an increased susceptibility to lyso-
zyme, an enzyme that hydrolyses the longitudinal pepti-
doglycan strands. This effect may be due to subtle changes 
in the peptidoglycan layer. However, a weakened cell wall 
structure was suggested by an increased susceptibility 
to DCS (Chacon et al., 2002), imipenem, polymyxin B and 
vancomycin. These findings are consistent with peptido-
glycan alterations as a result of the downshift in the d-al-
anine pool. 
Auxotrophic mutations decrease the intracellular sur-
vival of pathogenic micro-organisms, including mycobac-
teria (Appelberg, 2006; Crawford et al., 1996; Guleria et al., 
1996; Mintz et al., 1988). This effect may be related to the 
reduced availability of nutrients in the phagosome, in con-
trast to the relatively rich cytoplasmic compartment. In the 
case of mycobacteria, the vacuole is deficient in purines, 
amino acids, vitamins and other nutrients (Brown et al., 
2005; Hondalus et al., 2000; Jackson et al., 1999; Pavelka et 
al., 2003). Our studies suggest a combined effect of nutri-
ent deficiency and reactive intermediate molecules on the 
intracellular survival of mycobacteria inside nutrient-defi-
cient vacuoles. Inhibition of ROI and/or RNI may also re-
sult in metabolic changes in the phagosome that could al-
ter the attenuation of auxotrophic mutant strains. Mutants 
absolutely dependent on d-alanine for growth would likely 
autolyse in vivo, providing potentially safer auxotrophic 
vaccines. If the alr gene is essential in M. tuberculosis, as 
suggested by global genomic analysis (Sassetti et al., 2003), 
it may still be possible to engineer viable mutants by in-
troducing the M. smegmatis alternative pathway genes un-
der the control of a regulated promoter. Thus, these studies 
are significant for the development of novel live attenuated 
vaccines to control mycobacterial diseases. 
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Supplementary Figure S1. Growth curves of M. smegmatis parental, alr mutant and complemented strains in Middlebrook medium. 
Strains mc2155 (a), TAM23 (b), and TAM23 (pTAMU3) (c) were grown in MADC-TW with d-alanine. Cells were harvested, washed 
twice with PBS-TW, and inoculated 1:50 into MADC-TW. Growth (OD600) was recorded for 95 h. Symbols indicate growth with (open 
symbols) or without (filled symbols) d-alanine supplementation. 
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Supplementary Figure S2. Growth curves of M. smegmatis parental, alr mutant, and complemented strains in minimal medium. 
Strains mc2155 (a), TAM23 (b), and TAM23 (pTAMU3) (c) were grown in MADC-TW with d-alanine. Cells were harvested, washed 
twice with PBS-TW, and inoculated 1:50 into minimal medium. Growth (OD600) was recorded for 95 h for all strains except TAM23 
which was grown for 115 h. Symbols indicate growth with (open symbols) or without (filled symbols) d-alanine supplementation. 
Supplementary Figure S3. Susceptibility of M. smegmatis to reactive-intermediate-generating compounds. For H2O2 assays (a), 
cells were treated with increasing concentrations for 30 min and plated. For NaNO2 assays (b), cells were treated at pH 4.0 with 
or without 2 mM NaNO2 as these conditions yielded significant overnight killing. Symbols and line patterns are ●, mc
2155 without 
d-alanine; ■, TAM23 without d-alanine; ○, mc2155 with d-alanine; □, TAM23 with d-alanine; unbroken lines, mc2155 and TAM23 
with NaNO2; and dashed lines, mc
2
155 and TAM23 without NaNO2. Results are reported as means ±SEM, n = 3, with statistical 
significance displayed as NS, not significant (P > 0.05).
